NEW YORK, July 16, 2026 – UnitedHealth Group (NYSE:UNH) and Elevance Health (NYSE:ELV) both surpassed second-quarter earnings expectations, but the market response was starkly different. UnitedHealth shares surged nearly 5% in early premarket trading after the company raised the lower end of its 2026 adjusted EPS outlook by $1.25, following a quarterly beat of $1.48 per share. In contrast, Elevance shares closed down 8.7% on Wednesday after a more modest guidance lift of just $0.25, despite beating consensus by $1.24.
Guidance Quality Drives Divergence
The critical metric for investors is how much of the quarterly earnings surprise is incorporated into the full-year outlook. UnitedHealth folded at least 84% of its $1.48 beat into its new lower-end guidance of $19.50 per share, while Elevance moved only about 20% of its $1.24 beat into its updated floor of $27.00 per share. This basic measure helps distinguish sustainable earnings improvements from one-time items.
Baird analyst Michael Ha noted that expectations for Elevance were elevated heading into the quarter, and a headline beat was insufficient when guidance failed to shift materially. This left little room for a cautious outlook, contributing to the stock's decline.
Medical Cost Ratio and Reserve Development
UnitedHealth reported a medical cost ratio (MCR) of 86.7%, which benefited from an $860 million reduction in older claim reserves. Excluding this reserve development, the MCR would have been approximately 87.7%, still 0.8 percentage points better than consensus. The reserve release was primarily tied to 2026 dates of service, indicating that prior estimates were too conservative.
Elevance also flagged non-operating items contributing about $0.80 per share, or 65% of its $1.24 beat. Its care-cost ratio of 89.7% beat consensus by 0.45 points but rose 0.8 points year over year. Adjusted operating margin fell to 3.6% from 5.0% a year ago.
Membership and Margin Trends
Both insurers reported declining membership. UnitedHealthcare lost 525,000 members from March, but its operating margin improved to 4.6% from 2.4% in the prior-year quarter. Elevance shed 469,000 medical members, and its Health Benefits margin dropped to 2.1% from 3.8%. While business lines differ, the directional divergence underscores UnitedHealth's stronger execution.
UnitedHealth CEO Stephen Hemsley described the outlook as reflecting "continuing progress in our work to simplify how we operate," but CFO Wayne DeVeydt cautioned that the quarter was "not a reflection of a trend bending or coming under control." The company maintained its full-year revenue guidance of $439 billion and expects to lose about 500,000 Affordable Care Act plan members this year.
Elevance CEO Gail Boudreaux stated that the Medicaid margin outlook remains "appropriately prudent and unchanged from our prior guidance." The company plans additional Medicaid exits over the next 12 to 18 months and increased spending on medical cost management and member service. It continues to target at least 12% adjusted EPS growth in 2027.
Implications for Investors
The divergent guidance moves highlight the importance of earnings quality. UnitedHealth's decision to pass through most of its beat suggests confidence in its underlying performance, while Elevance's conservative approach reflects ongoing Medicaid headwinds and planned investments. However, UnitedHealth's reserve tailwind may not repeat, and membership declines could pressure revenue growth. For Elevance, higher state payments could ease Medicaid strain, but further market exits would shrink its footprint.
The first look at insurer results leaves investors with a key question: how much of the quarterly surprise shows up in annual guidance? UnitedHealth's answer was nearly all of it, while Elevance chose to hold back. That split—more than the headline EPS beats—is driving the big divergence in their stocks.
